![Michael P. Doyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael P.
Doyle worked as a Senior Director of Regulatory Affairs at Clovis Oncology, Inc. and as the Head of Regulatory Affairs at Novella Clinical, Inc. He also worked as the Vice President of Regulatory Affairs at Fresh Tracks Therapeutics, Inc. from 2016 to 2022.
Doyle holds a doctorate degree from the University of New Mexico School of Medicine.
| Empresas | Cargo | Fin |
|---|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Consejero General | 01/07/2022 |
Novella Clinical, Inc.
 Novella Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research development solutions | Consejero General | - |
| CLOVIS ONCOLOGY, INC. | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
University of New Mexico School of Medicine
 University of New Mexico School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novella Clinical, Inc.
Novella Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research development solutions | Commercial Services |
Fresh Tracks Therapeutics, Inc.
 Fresh Tracks Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops and manufactures prescription therapeutics products for the treatment of autoimmune, inflammatory and debilitating diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
